Scholars@Duke
Corrie Chumpitazi

Corrie Chumpitazi

Instructor Temporary In the Department of Pediatrics
Pediatrics, Emergency Medicine
corrie.chumpitazi@duke.edu
2301 Erwin Rd, Durham, NC 27710
2301 Erwin Rd, Durham, NC 27710

Scholarly Works - Conferences

Revisiting acute chest syndrome (ACS) associated with sickle cell disease (SCD) vaso-occlusive pain episodes (VOE): Insight from a prospective, multicenter Phase-3 randomized controlled trial

Conference Blood · November 3, 2025 AbstractBackground: ACS occurs in up to 20% of hospitalized patients with SCD-VOE, often prolonging and complicating hospital stay. Despite ... Full text Cite

Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): Results from a prospective multi-center randomized controlled trial (RCT)

Conference Blood · November 3, 2025 AbstractBackground: Acute chest syndrome (ACS) is the leading cause of morbidity and mortality in children with SCD, often developing durin ... Full text Cite

Sickle cell disease treatment with arginine therapy (STArT) – results of a phase-3 randomized controlled trial

Conference Blood · November 3, 2025 AbstractBackground: Vaso-occlusive pain episodes (VOE) are the leading cause of emergency department (ED) visits and hospitalizations for p ... Full text Cite

Impact of chronic pain on acute pain trajectories in sickle cell disease: Insights from the sickle cell disease treatment with arginine therapy (STArT) randomized controlled trial

Conference Blood · November 3, 2025 AbstractBackground/Methods: STArT (NCT04839354) was a phase-3 double-blind, randomized placebo-controlled trial of intravenous (IV) arginin ... Full text Cite

The psychometric properties of the stoplight pain scale in children with sickle cell disease

Conference Blood · November 3, 2025 AbstractBackground: Effective pain management begins with accurate pain assessment for children with sickle cell disease (SCD) experiencing ... Full text Cite

Race and ethnicity: Not factors in the prescribing of hydrocodone and codeine-containing products in two pediatric emergency departments.

Conference J Opioid Manag · 2019 OBJECTIVE: To describe the prescription of hydrocodone-containing products (HCPs) and codeine-containing products (CCPs) by patient and provider race and ethnicity at two pediatric emergency departments (EDs) before and after the US Drug Enforcement Admini ... Full text Link to item Cite